H. Watkins

H.
Thomas Watkins currently works at HemoShear Therapeutics, Inc., as Director, Chamber of Commerce of The United States of America, as Director, National Symphony Orchestra, as Director, and Mason School of Business of The College of William & Mary, as Trustee.
Mr. Watkins also formerly worked at Human Genome Sciences, Inc., as President, Chief Executive Officer & Director from 2011 to 2012, Vanda Pharmaceuticals, Inc., as Independent Director from 2011 to 2014, Biotechnology Innovation Organization, as Director from 2013 to 2019, Horizon Therapeutics Plc, as Independent Director from 2014 to 2023, The Lake Forest Hospital Foundation, as Director, Tech Council of Maryland, Inc., as Director, Horizon Pharma, Inc., as Independent Director, Abbott Laboratories, as Vice President-Diagnostics Operations from 1985 to 2004, and TAP Pharmaceutical Products, Inc., as President from 1998 to 2004.
Mr. Watkins received his undergraduate degree in 1974 from The College of William & Mary and Masters Business Admin degree in 1979 from The University of Chicago Booth School of Business.